A team of paleogeneticists is a winner of the 2024 Gizmodo Science Fair for recovering RNA from a museum specimen of a ...

A new statistical technique developed by a researcher at the Texas A&M University School of Public Health and colleagues ...

TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribe™ RNA ...

"This could be a game-changer for treating complex conditions where targeting multiple pathways is beneficial, such as cancer ...

Italian biotech Aptadir Therapeutics has launched with the promise that its pipeline of preclinical RNA inhibitors could ...

Goldman Sachs has initiated coverage on Avidity Biosciences with a Buy rating and a $59 price target, citing ...

Aptadir Therapeutics, a biotech focused on RNA inhibitor therapies for cancer and genetic conditions, has launched with $1.6 ...

Discover BioNTech SE's innovative RNA lipoplex patent, detailing advanced methods for stable RNA delivery, GMP production, and effective intravenous administration.

Aptadir Therapeutics (Aptadir), a biotech company developing RNA inhibitor-based therapeutics for treating intractable ...

Check the time stamp on this data. Updated AI-Generated Signals for Avidity Biosciences Inc. (RNA) available here: RNA.

Wave Life Sciences stock surged over 50% today due to promising data from its Duchenne Muscular Dystrophy candidate WVE-N531.